ClinicalTrials.Veeva

Menu
P

Pivotal Research Solutions, LLC. | Stonecrest, GA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Astegolimab
Povorcitinib
Tirzepatide
Eloralintide
Macupatide
LY3532226
LY3298176
Retatrutide
LY3437943
LY3841136

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 10 total trials

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

The purpose of this study is to investigate weight reduction with macupatide and eloralintide, alone or in combination, in adult participants with ob...

Enrolling
Overweight
Obesity
Drug: Macupatide
Drug: Macupatide Placebo

The main purpose of this study is to evaluate the efficacy and safety of retatrutide compared to tirzepatide in adults who have obesity. The study wi...

Active, not recruiting
Obesity
Drug: Retatrutide
Drug: Tirzepatide

This study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease (COP...

Enrolling
Chronic Obstructive Pulmonary Disease (COPD)
Drug: Astegolimab
Drug: Placebo

This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.

Active, not recruiting
NonSegmental Vitiligo
Drug: Placebo
Drug: Povorcitinib

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmo...

Enrolling
Chronic Obstructive Pulmonary Disease
Drug: Astegolimab

The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will evaluate t...

Active, not recruiting
Severe Asthma
Drug: Placebo
Drug: Verekitug (UPB-101)

This is a Phase 2, randomized, multicenter study in adult and adolescent participants with asthma and type 2 inflammation

Enrolling
Asthma Acute
Combination Product: Rademikibart in prefilled syringe
Drug: Matching placebo in prefilled syringe

This is a Phase 2, multicenter study in adult participants with an acute COPD exacerbation and type 2 inflammation

Enrolling
COPD Acute Exacerbation
Combination Product: Rademikibart in prefilled syringe
Drug: Matching placebo in prefilled syringe

The purpose of this randomized study is to demonstrate direct clinical benefit, i.e., observed benefits in how humans with COPD feel in terms of symp...

Enrolling
COPD
Smoking
Other: Cigarette
Other: THS

Trial sponsors

Lilly logo
Roche logo
C
Incyte logo
P
U
Vaxcyte logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems